Literature DB >> 16677862

The effect of the administration of human gamma globulins in a model of BCG infection in mice.

Nesty Olivares1, Annette León, Yamilé López, Alina Puig, Armando Cádiz, Gustavo Falero, Máximo Martínez, Marie E Sarmiento, Mildrey Fariñas, Juan F Infante, Gustavo Sierra, Rosa L Solís, Armando Acosta.   

Abstract

The effect of the administration of a commercial preparation of human gamma globulins has been evaluated in a mouse model of intranasal infection with BCG. First, we demonstrated the passage of specific antibodies to saliva and lung lavage following the intranasal or intraperitoneal administration to mice of human gamma globulins. This treatment of mice inhibited BCG colonization of the lungs (p < 0.01). A similar inhibitory effect was observed after infection of mice with gamma globulin opsonized BCG organisms (p < 0.01). These results are relevant for the development of new strategies for the control and treatment of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677862     DOI: 10.1016/j.tube.2006.01.006

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  13 in total

1.  Antibody mediated immunity - a missed opportunity in the fight against tuberculosis?

Authors:  Armando Acosta; Mohd Nor Norazmi; Maria Elena Sarmiento
Journal:  Malays J Med Sci       Date:  2010-04

2.  Role of estrogen receptor- α in an experimental model of bronchial asthma.

Authors:  Saloni P Shah; Priyanshee V Gohil; Gaurang B Shah
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

Review 3.  Th1 cytokines, true functional signatures for protective immunity against TB?

Authors:  Gucheng Zeng; Guoliang Zhang; Xinchun Chen
Journal:  Cell Mol Immunol       Date:  2017-11-20       Impact factor: 11.530

Review 4.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 5.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

6.  Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.

Authors:  Anke Ziegenbalg; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Ryung S Kim; Arturo Casadevall; Jacqueline M Achkar
Journal:  Tuberculosis (Edinb)       Date:  2013-04-02       Impact factor: 3.131

Review 7.  Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

8.  Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.

Authors:  Alberto R Cervantes-Villagrana; Rogelio Hernández-Pando; Arya Biragyn; Julio Castañeda-Delgado; Monica Bodogai; Margarita Martínez-Fierro; Eduardo Sada; Valentin Trujillo; Antonio Enciso-Moreno; Bruno Rivas-Santiago
Journal:  Vaccine       Date:  2012-11-26       Impact factor: 3.641

9.  Second international congress on immunopharmacology: delivery systems and current strategies for drug design.

Authors:  Reinaldo Acevedo; Mario Landys; Armando Acosta; Herve Bercovier; Mohd Nor Norazmi; Valerie Ferro; Maria Elena Sarmiento
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

10.  Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens.

Authors:  Rohimah Mohamud; Maryam Azlan; Daniel Yero; Nadine Alvarez; Maria E Sarmiento; Armando Acosta; Mohd-Nor Norazmi
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.